Previous 10 | Next 10 |
2024-06-08 14:00:00 ET More on Eli Lilly, Biogen Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer’s drug FDA suggests safety warning for Eli Lilly Alzheimer’s drug ...
2024-06-04 05:07:02 ET Summary Cassava Sciences is advancing simufilam, a Phase 3 drug for Alzheimer's, amid scrutiny over data integrity and trial conduct. Despite operational progress, significant concerns about simufilam's efficacy and the validity of clinical data persist. ...
2024-05-10 16:48:23 ET More on Cassava Sciences Cassava Sciences: New Year, Same Game Of Smoke And Mirrors Cassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go? Cassava Sciences GAAP EPS of -$0.43 beats by $0.03 Cassava Sciences raises ove...
2024-05-10 16:07:27 ET More on Cassava Sciences Cassava Sciences: New Year, Same Game Of Smoke And Mirrors Cassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go? Cassava Sciences raises over $125M from warrant distribution Cassava Sciences ...
$126.3 Million In Total Gross Proceeds from Warrant Distribution. Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam. Over 735 Patients Have Completed a Phase 3 Trial of Simufilam. AUSTIN, Texas, May 10, 2024 (GLOBE NE...
2024-05-09 20:43:22 ET Summary Recent results suggest that buntanetap, along with other treatments, does not significantly improve the condition of moderate Alzheimer's disease patients. Many current drug candidates for Alzheimer's disease work too far upstream in the disease proc...
2024-05-08 16:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-08 13:20:25 ET More on Cassava Sciences Cassava Sciences: New Year, Same Game Of Smoke And Mirrors Cassava Sciences: Where Did All The Mild Alzheimer's Disease Patients Go? Cassava Sciences And Alzheimer's Disease: Opaque Clarity Cassava Sciences agai...
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”), a biotechnology company focused on Alzheimer’s disease, today announced total gross proceeds of over $125 million from cash-exercises of warrants that were previously distri...
2024-05-07 10:47:03 ET ProShares UltraPro Short QQQ (SQQQ) SQQQ is trading DOWN for the last 4 days, and it at trading at $10.69 with volume of 30,905,666 and a one day change of $-0.01 (-0.09%). ProShares UltraPro Short QQQ has a 52-week low of 10.05 and a 52-week high of $29.28. T...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...